DRUG SURVIVAL AND CLINICAL EFFICACY OF 7 YEARS ETANERCEPT TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE GLAS COHORT

被引：1
|
作者：
Arends, S. [1 ,2 ]
Brouwer, E. [1 ]
Wink, F. [2 ]
Bos, R. [2 ]
Maas, F. [1 ]
Bootsma, H. [1 ]
van der Veer, E. [3 ]
Spoorenberg, A. [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands
[2] Med Ctr Leeuwarden, Rheumatol, Leeuwarden, Netherlands
[3] Univ Med Ctr Groningen, Lab Med, Groningen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4990
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0239
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [41] Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical data supported by magnetic resonance imaging
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [42] DRUG SURVIVAL AND SWITCHING RATE OF TNF INHIBITORS IN A COHORT OF PATIENTS WITH ANKYLOSING SPONDYLITIS WITH LONG TERM FOLLOW UP
    Klavdianou, K.
    Lazarini, A.
    Koutsianas, C.
    Tsalapaki, C.
    Thomas, K.
    Hatzara, C.
    Antonatou, K.
    Vassilopoulos, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1128 - 1128
  • [43] Retention Rate of Adalimumab, Etanercept, and Infliximab at 5 Years in Patients with Ankylosing Spondylitis: Report from the Rhumadata Computerized Database
    Choquette, Denis
    Sauvageau, Diane
    Raynauld, Jean-Pierre
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 994 - 994
  • [44] Ongoing clinical effectiveness and safety of treatment with Infliximab in patients with ankylosing Spondylitis over 6 years
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Alten, R.
    Burmester, G.
    Krause, A.
    Schewe, S.
    Schneider, S.
    Soerensen, H.
    Zeidler, H.
    Sieper, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 51 - 51
  • [45] PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKYLOSING SPONDYLITIS DEMONSTRATE THE SAME CLINICAL DISEASE COURSE OVER TWO YEARS: RESULTS FROM THE GESPIC COHORT
    Poddubnyy, D.
    Haibel, H.
    Braun, J.
    Rudwaleit, M.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 201 - 201
  • [46] Long term efficacy and safety of etanercept in patients with ankylosing spondylitis: 148 to 160 week analysis from an ongoing trial
    Sieper, J.
    Dijkmans, B. A. C.
    Van der Linden, S.
    Mola, E. Martin
    Sibilia, J.
    Leirisalo-Repo, M.
    Nab, H. W.
    Chang, D.
    Freundlich, B.
    MacPeeke, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 437 - 438
  • [47] Sustained clinical improvement in patients with psoriatic arthritis under etanercept treatment: 3-years results in prospective cohort
    de Vlam, Kurt L.
    Lories, Rik J. U.
    Janssen, Sarah
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S577 - S577
  • [48] Influence of infliximab therapy on radiographic progression in patients with ankylosing spondylitis: Results after four years of treatment
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [49] Persistent clinical efficacy and excellent safety over 5 years of treatment with the anti-TNFA agent infliximab in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Alten, R.
    Burmester, G.
    Gromnica-Ihle, E.
    Schewe, S.
    Schneider, M.
    Soerensen, H.
    Zeidler, H.
    Haibel, H.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 206 - 206
  • [50] Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: an observational, retrospective cohort study
    Huang, Zhi-Xiang
    Deng, Wei-Ming
    Guo, Xin
    Huang, Zheng-Ping
    Huang, Yu-Kai
    Lin, Chu-Lan
    Li, Tian-Wang
    CLINICAL RHEUMATOLOGY, 2019, 38 (06) : 1595 - 1604
12345